Melola Discovery

← Melola Discovery

Jurnal SINTA 1

Comparative Effectiveness of Tuberculosis Treatment Daily versus Intermittent Regimen in Indonesian TB-DM Patients: Real World Patient Database Study

ACTA MEDICA INDONESIANA · Vol. 52 No. 1 (2020)

ISSN
2338-2732, 0125-9326
Terbit
2020-04-14
Penerbit
The Indonesian Society of Internal Medicine
Bahasa
eng

Abstrak

Background: diabetes mellitus (DM) increases the risk of active TB by three times; there is no specific treatment strategy for tuberculosis-DM (TB-DM) patients. The 2017 WHO guidelines no longer recommended an intermittent regimen in the advanced phase of TB treatment due to higher risk of failure, relapse, and drug resistance compared to the daily regimen. This study aims to compare the effectiveness of treatment, in terms of clinical response and sputum conversion, of TB-DM patients in the advanced phase between the two-treatment delivery schedules. Methods: a retrospective cohort study from the medical records of patients from 1 January 2015 to 31 December 2018 at Persahabatan Hospital, Jakarta. The inclusion criteria are TB-DM patients aged >18 years with non-reactive HIV test, who have entered the advanced phase of category 1 TB treatment with smear positive at the time of diagnosis. Results: a total of 72 patients met the inclusion criteria. (75% male and 88.8% had at least 1+ smear results at the time of diagnosis). Thirty subjects still have positive smear at the beginning of the advance phase of treatment. After the advanced phase, 44.2% in the intermittent and 41.4% in the daily group were curedhaving sputum conversion. Seven subjects had side effects; but there were lots of dropouts and it is unclear whether they dropped because of side effects or not. Conclusion:there is no difference between sputum conversion profile and treatment success in advanced phase TB-DM treatment category 1 between the daily and intermittent regimen.ly for diabetic patients.

Kata kunci

Jaringan kolaborasi para penulis

33 penulis · 193 tautan kepenulisan bersama

Arahkan kursor atau ketuk sebuah nama untuk menyorot rekan penulisnya. Klik dua kali untuk membuka halaman penulis.

  • Udayana University
  • Universitas Nurul Jadid
  • Afiliasi tidak diketahui
  • Organisasi berbeda
  • Organisasi sama
  • Afiliasi tidak diketahui
  • Garis lebih tebal = lebih banyak artikel bersama · lingkaran lebih besar = lebih banyak artikel
Tampilkan sebagai tabel
Rekan penulisOrganisasiArtikel bersama
William WilliamUdayana University3
I Gusti Agung Ayu Putu Sri DarmayaniAfiliasi tidak diketahui2
Yani Jane R SugiriAfiliasi tidak diketahui2
Neni SawitriAfiliasi tidak diketahui2
Purwantyastuti PurwantyastutiAfiliasi tidak diketahui1
Nina MarianaAfiliasi tidak diketahui1
Adria RusliAfiliasi tidak diketahui1
Erlina BurhanAfiliasi tidak diketahui1
Rita RogayahAfiliasi tidak diketahui1
Agus Dwi SusantoAfiliasi tidak diketahui1
Ibrahim Nur Insan Putra DharmawanAfiliasi tidak diketahui1
Markus MeyerAfiliasi tidak diketahui1
ROBIATUL ADAWIYAHUniversitas Nurul Jadid1
Rudyanto SedonoAfiliasi tidak diketahui1
Erni Juwita NelwanAfiliasi tidak diketahui1
Mulya Rahma KaryantiAfiliasi tidak diketahui1
Anna RozaliyaniAfiliasi tidak diketahui1
Findra SetianingrumAfiliasi tidak diketahui1
Yulia Rosa SaharmanAfiliasi tidak diketahui1
Dita AditianingsihAfiliasi tidak diketahui1
Adityo SusiloAfiliasi tidak diketahui1
Mardiastuti WahidAfiliasi tidak diketahui1
Siti PratiekauriAfiliasi tidak diketahui1
Fathiyah IsbaniahAfiliasi tidak diketahui1
Vera IrawanyAfiliasi tidak diketahui1
Debbie LatupeirissaAfiliasi tidak diketahui1
Nina Dwi PutriAfiliasi tidak diketahui1
Winda SofvinaAfiliasi tidak diketahui1
Mulyati TugiranAfiliasi tidak diketahui1

Afiliasi berasal dari OpenAlex; metadata OAI-PMH jurnal tidak memuatnya. Penulis tanpa ID OpenAlex dicocokkan berdasarkan nama, sehingga dua orang bisa tergabung atau satu orang bisa terpisah.

Sumber metadata: OAI-PMH (metadata jurnal) http://www.actamedindones.org/index.php/ijim/oai, pertama di-harvest 8 Nov 2026, terakhir terlihat 16 Nov 2026.
Metadata asli (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">Comparative Effectiveness of Tuberculosis Treatment Daily versus Intermittent Regimen in Indonesian TB-DM Patients: Real World Patient Database Study</dc:title>
	<dc:creator>Siane, Angelina</dc:creator>
	<dc:creator>Ascobat, Purwantyastuti</dc:creator>
	<dc:creator>Instiaty, Instiaty</dc:creator>
	<dc:creator>Agustin, Heidy</dc:creator>
	<dc:subject xml:lang="en-US">TB-DM</dc:subject>
	<dc:subject xml:lang="en-US">diabetes mellitus</dc:subject>
	<dc:subject xml:lang="en-US">advanced phase</dc:subject>
	<dc:subject xml:lang="en-US">intermittent treatment</dc:subject>
	<dc:subject xml:lang="en-US">daily treatment</dc:subject>
	<dc:subject xml:lang="en-US">treatment success</dc:subject>
	<dc:subject xml:lang="en-US">tuberculosis and diabetes mellitus</dc:subject>
	<dc:description xml:lang="en-US">Background: diabetes mellitus (DM) increases the risk of active TB by three times; there is no specific treatment strategy for tuberculosis-DM (TB-DM) patients. The 2017 WHO guidelines no longer recommended an intermittent regimen in the advanced phase of TB treatment due to higher risk of failure, relapse, and drug resistance compared to the daily regimen. This study aims to compare the effectiveness of treatment, in terms of clinical response and sputum conversion, of TB-DM patients in the advanced phase between the two-treatment delivery schedules. Methods: a retrospective cohort study from the medical records of patients from 1 January 2015 to 31 December 2018 at Persahabatan Hospital, Jakarta. The inclusion criteria are TB-DM patients aged &amp;gt;18 years with non-reactive HIV test, who have entered the advanced phase of category 1 TB treatment with smear positive at the time of diagnosis. Results: a total of 72 patients met the inclusion criteria. (75% male and 88.8% had at least 1+ smear results at the time of diagnosis). Thirty subjects still have positive smear at the beginning of the advance phase of treatment. After the advanced phase, 44.2% in the intermittent and 41.4% in the daily group were curedhaving sputum conversion. Seven subjects had side effects; but there were lots of dropouts and it is unclear whether they dropped because of side effects or not. Conclusion:there is no difference between sputum conversion profile and treatment success in advanced phase TB-DM treatment category 1 between the daily and intermittent regimen.ly for diabetic patients. </dc:description>
	<dc:publisher xml:lang="en-US">The Indonesian Society of Internal Medicine</dc:publisher>
	<dc:date>2020-04-14</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>http://www.actamedindones.org/index.php/ijim/article/view/1370</dc:identifier>
	<dc:source xml:lang="en-US">Acta Medica Indonesiana; Vol. 52 No. 1 (2020): Acta Medica Indonesiana; 25</dc:source>
	<dc:source>2338-2732</dc:source>
	<dc:source>0125-9326</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>http://www.actamedindones.org/index.php/ijim/article/view/1370/pdf</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2020 Acta Medica Indonesiana</dc:rights>
</oai_dc:dc>